Erratum: Retinoblastoma: An overview (Indian Journal of Pediatrics DOI: 10.1007/s12098-012-0726-8);Retinoblastoma: An overview

Indian Journal of Pediatrics

Volumn 79, Issue 7, 2012, Pages 916-921

  Ray, Anish ^a   Gombos, Dan S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Enucleation; Radiotherapy; Retinoblastoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PLATINUM COMPLEX; THIOTEPA; VINCRISTINE;

ADVANCED CANCER; ALLELE; ASPIRATION CYTOLOGY; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMOEMBOLIZATION; CHROMOSOME 13Q; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EXTRAOCULAR RETINBLASTOMA; EXTRAOCULAR RETINOBLASTOMA; EYE EXAMINATION; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; LEUKOKORIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NONMYELOABLATIVE CONDITIONING; NUCLEAR MAGNETIC RESONANCE IMAGING; RETINOBLASTOMA; REVIEW; RISK ASSESSMENT; RISK FACTOR; STRABISMUS; TRILATERAL RETINBLASTOMA; TRILATERAL RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

EID: 84866737867     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-012-0781-1     Document Type: Erratum

References (35)

1. Young JL, Smith MA, Roffers SD, et al. Retinoblastoma. In: Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer incidence and survival among children and adolescents: united states SEER program 1975-1995. Bethesda: National Cancer Institute; 1999.
2. Berkeley JS, Kalita BC. Retinoblastoma in an adult. Lancet. 1977;2:508-9.
3. Wong FL, Boice JD, Abramson DH, et al. Cancer incidence after retinoblastoma - Radiation dose and sarcoma risk. JAMA. 1997;278:1262-7.
4. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer. 2005;5:91-101.
5. Knudson AG Jr, Hethcote HW, Brown BW. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA. 1975;72:5116-20.
6. Hurwitz RL, Shields CL, Shields JA, Chevez-Barrios P, Hurwitz MY, Chintagumpala MM. Retinoblastoma. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 865-86.
7. Bader JL, Meadows AT, Zimmerman LE, et al. Bilateral retinoblastoma with ectopic intracranical retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet. 1982;5:203-13.
8. Piro PA Jr, Abramson DH, Ellsworth RM, Kitchin D. Aqueous humor lactate dehydrogenase in retinoblastoma patients. Clinicopathologic correlations. Arch Ophthalmol. 1978;96:1823-5.
9. Karcioglu ZA. Fine needle aspiration biopsy (FNAB) for retinoblastoma. Retina. 2002;22:707-10.
10. Lindley J, Smith S. Histology and spontaneous regression of retinoblastoma. Trans Ophthalmol Soc UK. 1974;94:953-67.
11. Kao LY, Yang ML. Spontaneous regression of retinoblastoma in a Taiwan series. J Pediatr Ophthalmol Strabismus. 2005;42:228- 32.
12. Stiller CA. Population-based survival rates for childhood-cancer in Britain, 1980-91. BMJ. 1994;309:1612-6.
13. Messmer EP, Heinrich T, Hopping W, Desutter E, Havers W, Sauerwein W. Risk-factors for metastases in patients with retinoblastoma. Ophthalmology. 1991;98:136-41.
14. Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic-nerve invasion of retinoblastoma - metastatic potential and clinical riskfactors. Cancer. 1994;73:692-8.
15. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma - metastatic potential and clinical riskfactors. Br J Ophthalmol. 1993;77:544-8.
16. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269-72.
17. Antoneli CBG, Ribeiro KB, Rodrigue-Galindo C, et al. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol. 2007;29:700-4.
18. Palma J,Sasso DF, Dufort G, et al. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America. Bone Marrow Transplant. 2011. May 23 [Epub ahead of print]
19. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17:228-34.
20. Hilgartner HL. Report of case of double glioma treated with x-ray 1903. Tex Med. 2005;101:10.
21. Peylan-Ramu N, Bin-Nun A, Skleir-Levy M, et al. Orbital growth retardation in retinoblastoma survivors: work in progress. Med Pediatr Oncol. 2001;37:465-70.
22. Eng C, Li FP, Abramson DH, et al. Mortality from 2nd tumors among long-Term survivors of retinoblastoma. J Nat Cancer Inst. 1993;85:1121-8.
23. Reisner ML, PaisViégas CM, Grazziotin RZ, et al. Retinoblastoma - Comparative analysis of external radiotherapy techniques, including an IMRT technique. Int J Radiat Oncol Biol Phys. 2007;67:933-41.
24. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005;63:362-72.
25. Mohan ER, Verma M, Kumar K, et al. Clinico-pathological profile of orbital exenteration in a tertiary eye care institute: 7 year experience. Bangalore; AIOC Proceedings. 2008.
26. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma - Long-Term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116-21.
27. Shields JA, Shields CL, Parsons H, Giblin ME. The role of photocoagulation in the management of retinoblastoma. Arch Ophthalmol. 1990;108:205-8.
28. Shields JA, Parsons H, Shields CL, Giblin ME. The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol. 1989;108:260-4.
29. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138:329-37.
30. Chan HSL, Gallie BL, Munier FL, Popovic MB. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18:55-63.
31. Gombos DS, Kelly A, Coen PG, Kingston JE, Hungerford JL. Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol. 2002;86:80-3.
32. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intraarterial chemotherapy for the management of retinoblastoma: fouryear experience. Arch Ophthalmol. 2011;129:731-7.
33. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Supraselective intra-Arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol. 2011;5:171-6.
34. Tsuruta T, Aihara Y, Kanno H, et al. High-dose chemotherapy followed by autologous and allogeneic peripheral blood stem cell transplantation for recurrent disseminated trilateral retinoblastoma. Childs Nerv Syst. 2011;27:1019-24.
35. Demers GW, Harris MP, Wen SF, Engler H, Nielsen LL, Maneval DC. A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth. Cancer Gene Ther. 1998;5:207-14.